© John Wiley & Sons Ltd
Editors-in-Chief: David Morgan, Thomas Permutt and Gerd Rosenkranz
Impact Factor: 1.235
ISI Journal Citation Reports © Ranking: 2015: 45/123 (Statistics & Probability); 209/255 (Pharmacology & Pharmacy)
Online ISSN: 1539-1612
Welcome to the new Editor-in-Chief
We are delighted to welcome David Morgan as one of three Editors-in-Chief of Pharmaceutical Statistics.
David Morgan is a seasoned drug development professional with experience in UK, US, German and French pharmaceutical companies. He has degrees in Mathematics and in Applied Statistics from Oxford University and is a Chartered Mathematician and Chartered Statistician. David was Chairman of PSI (Statisticians in the Pharmaceutical Industry) from 1995 to 1997 and President of EFSPI (European Federation of Statisticians in the Pharmaceutical Industry) from 2001 to 2003.
David joins existing editors Thomas Permutt and Gerd Rosenkranz in the role.
Recently Published Articles
- You have full text access to this OnlineOpen articleΑ Markov model for longitudinal studies with incomplete dichotomous outcomes
Orestis Efthimiou, Nicky Welton, Myrto Samara, Stefan Leucht, Georgia Salanti and on behalf of GetReal Work Package 4
Version of Record online: 5 DEC 2016 | DOI: 10.1002/pst.1794
- Corrections: The disagreeable behaviour of the kappa statistic
Laura Flight and Steven A. Julious
Version of Record online: 2 DEC 2016 | DOI: 10.1002/pst.1795This article corrects:
Vol. 14, Issue 1, 74–78, Version of Record online: 3 DEC 2014